Résultats: 53

    Guideline No. 432c: induction of labour

    J. obstet. gynaecol. Can; 45 (1), 2023
    This guideline presents evidence and recommendations for cervical ripening and induction of labour. It aims to provide information to birth attendants and pregnant individuals on optimal perinatal care while avoiding unnecessary obstetrical intervention. Consistent interprofessional use of the guideline,...

    Guideline nº 431: postpartum hemorrhage and hemorrhagic shock

    J. obstet. gynaecol. Can; 44 (2), 2022
    This guideline aims to provide evidence for prevention, recognition, and treatment of postpartum hemorrhage including severe hemorrhage leading to hemorrhagic shock. Benefits, harms, and costs Appropriate recognition and treatment of postpartum hemorrhage can prevent serious morbidity while reducing cost...

    Directive clinique no 430: diagnostic et prise en charge de la rupture prématurée des membranes avant terme

    J. obstet. gynaecol. Can; 44 (11), 2022
    Fournir des directives claires et concises pour le diagnostic et la prise en charge de la rupture prématurée des membranes avant terme (RPMAT). Population cible Toute patiente manifestant une rupture prématurée des membranes avant 37 semaines d’aménorrhée. Bénéfices, risques et coûts La prése...

    Medical nutrition therapy in obesity management

    Healthy eating is important for all Canadians, regardless of body size, weight or health condition. Key messages from Canada’s Food Guide for Healthy Eating can be used as a foundation for nutrition and food-related education (Figure 1). Use evidence-based nutrition resources to give your patients nutr...

    Pharmacotherapy for obesity management

    Pharmacological treatments are an effective and scalable approach to treating obesity. As with any chronic disease, such as type 2 diabetes (T2DM) or hypertension, pharmacotherapy is an important pillar in the management of obesity. The focus of obesity management should be the improvement of health para...

    Technical update nº 433: eHealth solutions for urinary incontinence among women

    The purpose of this technical update is to establish the state of the science regarding emerging and novel electronic health (eHealth) and mobile health (mHealth) solutions for urinary incontinence among women. Target population Women over 18 years with urinary incontinence. Websites and mobile health ap...

    Mise à jour technique nº 429: Artéfact de la fréquence cardiaque maternelle pendant la surveillance du bien-être fœtal per partum

    J. obstet. gynaecol. Can; 44 (9), 2022
    Améliorer les issues périnatales et réduire au minimum le risque d’erreurs chez les fournisseurs en améliorant leurs connaissances sur les stratégies de détection des artéfacts de la fréquence cardiaque maternelle per partum et sur les modes d’intervention lorsque de tels artéfacts sont soup...

    Primary care and primary healthcare in obesity management

    Primary care clinicians should initiate patient-centred conversations with their patients about overweight or obesity. The 5As of Obesity ManagementTM (Ask-Assess-Advise-Agree-Assist) approach, starting with asking permission to discuss weight, is an appropriate format to use. Primary care clinicians sho...

    Guideline No 428: management of dichorionic twin pregnancies

    J. obstet. gynaecol. Can; 44 (7), 2022
    To review evidence-based recommendations for the management of dichorionic twin pregnancies. Pregnant women with a dichorionic twin pregnancy. Implementation of the recommendations in this guideline may improve the management of twin pregnancies and reduce neonatal and maternal morbidity and mortality. P...

    Guideline No 427: folic acid and multivitamin supplementation for prevention of folic acid–sensitive congenital anomalies

    J. obstet. gynaecol. Can; 44 (6), 2022
    To provide updated guidance on pre-conception folic acid and multivitamin supplementation for primary and secondary (recurrence) prevention of neural tube defects and other folate-sensitive congenital anomalies. Women aged 12-45 years who could become pregnant should be aware of the risk of serious birth...